Sera Prognostics Inc SERA

NAS: SERA | ISIN: US81749D1072   17/05/2024
8,260 USD (-1,43%)
(-1,43%)   17/05/2024

8 mei 2024 · Sera Prognostics Reports First Quarter 2024 Financial Results · Persbericht

29 april 2024 · Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 · Persbericht

20 maart 2024 · Sera Prognostics Reports Fourth Quarter 2023 Financial Results · Persbericht

4 maart 2024 · Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024 · Persbericht

29 februari 2024 · Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference · Persbericht

6 december 2023 · Sera Prognostics Announces Primary Endpoint Criteria Met In Pivotal Prime Study Interim Look - Enrollment To Stop Due To Success · Persbericht

8 november 2023 · Sera Prognostics Reports Third Quarter 2023 Financial Results · Persbericht

25 oktober 2023 · Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 · Persbericht

21 september 2023 · Sera Prognostics To Present At Cantor Fitzgerald Global Healthcare Conference 2023 · Persbericht

9 augustus 2023 · Sera Prognostics Reports Second Quarter 2023 Financial Results · Persbericht

31 juli 2023 · Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023 · Persbericht

25 mei 2023 · Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue · Persbericht

15 mei 2023 · Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO · Persbericht

10 mei 2023 · Sera Prognostics Reports First Quarter 2023 Financial Results · Persbericht

27 april 2023 · Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023 · Persbericht

22 maart 2023 · Sera Prognostics Reports Fourth Quarter 2022 Financial Results · Persbericht

9 maart 2023 · Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023 · Persbericht

23 februari 2023 · Sera Prognostics To Present At Upcoming March Investor Conferences · Persbericht

15 februari 2023 · Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL · Persbericht

29 november 2022 · FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS · Persbericht

Mijn selecties